| Parent Drug Name | Name of Impurity | Catalogue No. | |
|---|---|---|---|
| Cobicistat | Cobicistat Impurity 2 (3HCl Salt) | VE0013871 | View |
| Cobicistat | Cobicistat Impurity 4 | VE0013872 | View |
| Cobicistat | Cobicistat Impurity 5 | VE0013873 | View |
| Cobicistat | Cobicistat Impurity 9 (2HCl) | VE0013874 | View |
| Cobicistat | Cobicistat-D8 | DVE00420 | View |
| Cobicistat | Hydroxy Cobicistat | VE0013869 | View CAS 1051463-40-1 |
[rfq_list]
| Catalogue No. | VE0013869 |
| CAS No. | 1051463-40-1 |
| Molecular Formula | C40H53N7O6S2 |
| Molecular Weight | 792.03 g/mol |
| Parent drug | Cobicistat |
| IUPAC Name | thiazol-5-ylmethyl ((2R, 5R)-5-((S)-2-(3-((2-(2-hydroxypropan-2-yl)thiazol-4-yl)methyl)-3-methylureido)-4-morpholinobutanamido)-1, 6-diphenylhexan-2-yl)carbamate |
| Synonyms | N/A |
| Smiles | – |
| References | – |
| Status | In-stock |
| ListName | Hydroxy Cobicistat |
| Exclusively Supplied by Veeprho | Exclusively Supplied by Veeprho |
"*" indicates required fields
